.

BRC 2013 Research Day Panelist Bios


Steven Beyea
is a research scientist and scientific lead for the Biomedical Translational Imaging Centre (BIOTIC) at the IWK and CDHA Health Centres, and an Associate Professor in the Department of Radiology at Dalhousie. His work in medical imaging physics focuses on the development and translation of novel approaches to diagnostic image acquisition and analysis. Through his role as the scientific lead for BIOTIC he oversees a scientific team that encompasses expertise in human MRI, MEG/EEG, and pre-clinical imaging using MRI as well as PET/SPECT/CT. His work is funded through both conventional academic NSERC and CIHR grants as well through industry partnership initiatives such NSERC ENGAGE and ACOA's AIF program. Partnering with companies ranging from start-ups to MNEs, he has worked with numerous companies in the neurotechnology space to both perform technology development and efficacy validation across a spectrum of clinical applications.

Lloyd Brown has been involved with the health sector since 1970, as a clinician, administrator and consultant. He spent 29 years as Senior Vice President and President/CEO of the Northwood group of companies and for the past four years has been the Executive Director of the Alzheimer Society of Nova Scotia. With the dramatic rise of dementia worldwide, he is passionate about supporting people in the dementia journey, their families and their care givers. The Alzheimer Society is committed to the development of both a national and a provincial dementia strategy as a means to responding to the dramatic increase in dementia within our lifetimes.

Mike Cullen retired three years ago to become the full-time caregiver for his wife, Judy, who has had MS for over 16 years. His job took him away from home, and Judy was facing increasing challenges with mobility, stability and, to a lesser extent, cognition. Since Judy’s diagnosis, Mike has been involved with MS support groups in the HRM, which has allowed him to attend many information sessions concerning MS. Prior to his wife's MS, Mike and his sister cared for their mother, who suffered from dementia. He is one of approximately 35 caregivers who were interviewed by St. Mary's Hospital, of Montreal, about their experiences as caregivers. The interviews are now available at www.healthexperiences.ca/en/caregiving    

Bob Shaw is CEO of the Parkinson Society Maritime Region. Prior to taking this staff role with the society in 2012, he served as a volunteer on the regional and national Boards for the past 10 years—most recently as National Vice Chair of the Parkinson Society Canada Board of Directors. Bob’s task is to redesign the strategic and organizational direction of the Parkinson Society within the Maritimes, where the health charity has had up to 24 local organizational entities in the form of chapters and support groups. His focus is governance, fiscal management, human capital (both staff and volunteer), communications, relationship management (internal and external) and revenue development. The organization’s “Mission Pillars” are funding research of national scope, facilitating advocacy to the pharmaceutical and government sectors, developing education materials specific to Parkinson’s disease, and the promotion, design and execution of support programming delivered primarily at the grassroots level.

Neil Ritchie is President of Invicta Health. Neil is a social entrepreneur who develops, finances and manages innovative health-related technology businesses. Over his career in the health industry, across Canada, Neil has moved between both public and private sectors. He has worked as an executive in both community hospitals and large academic health sciences centers. Neil was an investment analyst with MDS Capital Corp and ACF Equity Ltd. and founded the Business Development Office in Dalhousie University’s Faculty of Medicine. He has led the development of five health-related start-up companies, the first of which was Nova Neuron, a Dalhousie spin-off. Neil currently leads a cloud-based health solutions company that is focused on improving patient’s experience of health care. He holds a Bachelor of Science Degree from Dalhousie University and a Master’s in Health Services Administration from the University of Alberta.

Kimberly Carter is President and CEO of the ALS Society of Nova Scotia. She is often asked two questions: Isn’t it hard (and sad) to work for people who are dying? And, what do you tell people when they are first diagnosed with such a dreadful disease? She responds that ALS Society staff don’t focus on the fact that they are working for people who are dying. They are working for people who are LIVING. And that’s what they tell people when they are first diagnosed. You still have life in your body, life in your spirit. Then the hard question is asked—how are you going to live with ALS and how can we help you do it? Most people choose to live as well as they can as long as they can and Kimberly reports that people who choose to “live” with ALS are amazing examples of grace and courage. While the ALS research community draws closer to understanding all the causes of and one day a cure for ALS, the staff team at ALS NS learns something from each new person diagnosed. Both the daily, practical coping skills and life lessons help the staff as they in turn help each new person diagnosed. After 20 years in the non-profit sector, Kimberly has learned the most about life, service, and courage from her tenure at the ALS Society of NS.

Scott Moffitt is the managing director of BioNova, Nova Scotia’s life sciences and biotechnology industry association, where he is helping the province’s industry to grow.  He was previously employed with BioNova as its Medical Technology Development Officer.
Scott is a senior management professional with 16 years of life science experience in industry, government and the non-profit world.  By leveraging his leadership and management abilities, Scott has built solid relationships and delivered significant results in each position he has held. In 2012, Scott served as the Senior Investment Officer - Bioscience, for Innovation PEI, the lead economic development agency for the Province of Prince Edward Island. Prior to his first stint with BioNova, he served as the marketing manager for the microbiology division of Thermo Fisher Scientific, where he was responsible for overall market development, and before that, he was the business development manager for the company.

Marli MacNeil has been the Chief Executive Officer of BioNova—the Nova Scotia biotechnology and life sciences industry association—since June 2002.  BioNova is Nova Scotia’s life sciences organization, representing companies working in pharmaceuticals/vaccines, medical technologies, natural health products/ nutraceuticals, digital health and bioproducts, as well as research organizations, service providers and other suppliers. Prior to joining BioNova, Marli served as executive director of the Aquaculture Association of Nova Scotia and was President of the Canadian Aquaculture Industry Alliance.  She is passionate about commercialization of local research for local economic development.  She serves as chair of the Dalhousie University Biomedical Engineering CREATE program, is a member of the Management Committee for the Dalhousie University RADIANT CREATE program, a member of the selection jury for the NSERC Synergy Awards, a member of the Halifax Chamber of Commerce’s Provincial Affairs Committee, and has been a director of several national and international organizations.

Kenneth Rockwood, Professor of Medicine (geriatrics and neurology) has a longstanding interest in clinical and epidemiological aspects of frailty, dementia and delirium. Over the last 20 years, working with the mathematician Arnold Mitnitski, this has evolved to focus on the complexity of frailty. As it turns out, complexity can be understood in mathematical terms, as more than a synonym for complicated. By applying insights from mathematics to the daily care of frail older adults, he is engaging in what can be termed “clinico-mathematical correlation.” For the last seven years, in addition to his memory clinics, most of his clinical work is in the Capital District Health Authority as the Department of Medicine’s Senior Internist, doing internal medicine consultations in the Emergency Department.

Dr. Rockwood has published more than 300 peer-reviewed scientific publications and seven books, including the seventh edition of the Brocklehurst’s Textbook of Geriatric Medicine & Gerontology. He is the Kathryn Allen Weldon Professor of Alzheimer research at Dalhousie University. He holds peer-reviewed grants totalling $6.7 million.

David Roach is an Assistant Professor in the School of Business Administration at Dalhousie University where he teaches master’s level courses in entrepreneurship, innovation and the commercialization of biomedical technologies. He also lectures internationally in the areas of innovative entrepreneurship, product design and development and marketing technology products. Dr. Roach has been instrumental in many early-stage companies ranging from aerospace to biotechnology and brings a hands-on approach to the innovation process. He sits on the board of directors and acts in an advisory capacity for several small and medium-size enterprises in Canada. His research interests include product management practices of SMEs.

Sunday the 22nd. © 2017. All rights reserved.. Bridgewater Media Services